The reporter learned from the Medical Insurance Bureau of Hainan Province that starting from 0: 00 on July 30, Hainan Province will officially implement the results of the centralized procurement of drugs in two inter-provincial alliances, among which the third batch of centralized procurement in eight provinces and two districts involves six drugs, with an average decline of 54.76% and the highest decline of 98.02%. The inter-provincial alliance of Chinese patent medicines led by Hubei involves 7 product groups in Hainan Province, with a total of 19 drugs, with an average decline of over 40% and the largest decline of 82.63%. It is reported that the two inter-provincial alliance drug varieties cover antibiotics, colds, rheumatoid arthritis, cardiovascular and cerebrovascular diseases, chronic kidney disease and other common diseases and chronic diseases, which continuously enrich the choice of drugs for patients in Hainan Province. In addition to the sharp price reduction of selected drugs, Hainan also linked the prices of non-selected drugs with generic names, and guided other non-selected drugs to reduce prices through measures such as payment standard limitation, so as to promote hospitals to give priority to the use of selected drugs with reliable quality and reasonable price, and guide and standardize diagnosis and treatment behavior.
In the next step, Hainan will successively land the results of over 400 centralized drugs selected by the seventh batch of national centralized drugs and Guangdong provincial alliance, continue to expand the scope of centralized drug procurement, and do a good job in monitoring the use of non-selected high-priced drugs and alternative drugs by medical institutions designated by medical insurance, so that the people can enjoy better and affordable medical services, and the reform dividend will benefit the whole island.
(Reporter Ye Fei, General Desk)
关于作者